Rheum core content.
#Chapter4, @eular_org online course #EULARonlinecourseOnRheumaticDiseases.
@EMEUNET initiative #EMEUNETonCourse, to promote knowledge-sharing in rheumatology.
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
Graphs show seropositive and seronegative patients. Something with MTX and B cells!
onlinelibrary.wiley.com/doi/epdf/10.10…
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.
No long-term superiority of the MTX + ADA combination.
academic.oup.com/rheumatology/a…
Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.
Initial differences in disease activity and structural progression did not seem to persist after 10 years.
annals.org/aim/fullarticl…
Therapies for active rheumatoid arthritis after methotrexate failure.
Triple therapy added to methotrexate was noninferior to etanercept plus methotrexate in patients with MTX refractory RA.
nejm.org/doi/pdf/10.105…
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug.
Non-TNF targeted biologic showed better efficacy.
jamanetwork.com/journals/jama/…
Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis.
It is indeed possible to taper TNFi therapy.
bmj.com/content/350/bm…